# AVROBIO Inc. (AVRO)

Source: https://www.quantisnow.com/company/AVRO
Generated: 2026-11-08T06:14:24.523Z

- Ticker: AVRO
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2018
- Website: avrobio.com

## About

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's lead product candidate is AVR-RD-01, a gene therapy which is in ongoing company-sponsored Phase 2 clinical trial and investigator-sponsored Phase 1 clinical trial for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in Phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, which is in preclinical development to treat Pompe disease; AVR-RD-04 that is in investigator-sponsored Phase 1/2 clinical trial to treat cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage to treat Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

## Latest AVRO news and filings

- 2024-06-26 12:00 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by AVROBIO Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-avrobio-inc-5577648)
- 2024-06-26 01:52 UTC [SEC Form 8-K] [AVROBIO Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/avrobio-inc-filed-sec-form-8-k-regulation-fd-disclosure-5577310)
- 2024-06-25 20:23 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by AVROBIO Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-avrobio-inc-5576580)
- 2024-06-25 17:42 UTC [SEC Form 4] [Former 10% owner of AVROBIO Leonard Braden Michael acquired 433,688 shares (SEC Form 4)](https://www.quantisnow.com/insight/former-10-owner-of-avrobio-leonard-braden-michael-acquired-433688-5576099)
- 2024-06-24 20:37 UTC [SEC Form 4] [SEC Form 4 filed by Director Donenberg Phillip B.](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-donenberg-phillip-b-5574100)
- 2024-06-24 20:35 UTC [SEC Form 4] [Director Vitorovic Stefan was granted 1,028,674 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-vitorovic-stefan-was-granted-1028674-shares-sec-form-4-5574086)
- 2024-06-24 20:34 UTC [SEC Form 3] [SEC Form 3 filed by new insider Vitorovic Stefan](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-vitorovic-stefan-5574071)
- 2024-06-24 20:32 UTC [SEC Form 4] [Director Tipirneni Praveen P. was granted 3,037 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-tipirneni-praveen-p-was-granted-3037-shares-sec-form-5574043)
- 2024-06-24 20:31 UTC [SEC Form 3] [SEC Form 3 filed by new insider Tipirneni Praveen P.](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-tipirneni-praveen-p-5574033)
- 2024-06-24 20:30 UTC [SEC Form 4] [Director Springer Timothy A was granted 4,243,121 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-springer-timothy-a-was-granted-4243121-shares-sec-form-5573982)
- 2024-06-24 20:29 UTC [SEC Form 3] [SEC Form 3 filed by new insider Springer Timothy A](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-springer-timothy-a-5573949)
- 2024-06-24 20:27 UTC [SEC Form 4] [Director Mcguire Terrance was granted 1,157,976 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-mcguire-terrance-was-granted-1157976-shares-sec-form-4-5573912)
- 2024-06-24 20:26 UTC [SEC Form 3] [SEC Form 3 filed by new insider Mcguire Terrance](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-mcguire-terrance-5573909)
- 2024-06-24 20:25 UTC [SEC Form 4] [SEC Form 4 filed by Chief Business Officer Schwabish Marc](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-business-officer-schwabish-marc-5573895)
- 2024-06-24 20:24 UTC [SEC Form 3] [SEC Form 3 filed by new insider Schwabish Marc](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-schwabish-marc-5573891)
- 2024-06-24 20:22 UTC [SEC Form 4] [Chief Medical Officer Ruddy Marcella K. was granted 32,065 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-medical-officer-ruddy-marcella-k-was-granted-32065-shares-5573861)
- 2024-06-24 20:21 UTC [SEC Form 3] [SEC Form 3 filed by new insider Ruddy Marcella K.](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-ruddy-marcella-k-5573852)
- 2024-06-24 20:20 UTC [SEC Form 4] [Chief Scientific Officer Mcnamara Peter was granted 10,688 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-scientific-officer-mcnamara-peter-was-granted-10688-shares-sec-5573835)
- 2024-06-24 20:19 UTC [SEC Form 3] [SEC Form 3 filed by new insider Mcnamara Peter](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-mcnamara-peter-5573827)
- 2024-06-24 20:18 UTC [SEC Form 4] [SEC Form 4 filed by Chief Financial Officer Lochner Daniel](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-financial-officer-lochner-daniel-5573810)
- 2024-06-24 20:17 UTC [SEC Form 3] [SEC Form 3 filed by new insider Lochner Daniel](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-lochner-daniel-5573805)
- 2024-06-24 20:16 UTC [SEC Form 4] [Chief Operating Officer Cortis Christian was granted 126,368 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-operating-officer-cortis-christian-was-granted-126368-shares-sec-5573796)
- 2024-06-24 20:15 UTC [SEC Form 3] [SEC Form 3 filed by new insider Cortis Christian](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-cortis-christian-5573784)
- 2024-06-24 20:12 UTC [SEC Form 4] [Chief Executive Officer Reicin Alise was granted 291,110 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-reicin-alise-was-granted-291110-shares-sec-5573744)
- 2024-06-24 20:11 UTC [SEC Form 3] [SEC Form 3 filed by new insider Reicin Alise](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-reicin-alise-5573730)
- 2024-06-20 23:50 UTC [Market Chatter] [Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending](https://www.quantisnow.com/insight/trading-halt-halted-at-75000-pm-et---trading-halt-5569600)
- 2024-06-20 20:25 UTC [SEC Form 8-K] [AVROBIO Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Leadership Update, Entry into a Material Definitive Agreement, Changes in Registrant's Certifying Accountant, Results of Operations and Financial Condition, Material Modification to Rights of Security Holders, Changes in Control of Registrant](https://www.quantisnow.com/insight/avrobio-inc-filed-sec-form-8-k-completion-of-acquisition-or-5568852)
- 2024-06-18 15:51 UTC [SEC Form 8-K] [Amendment: SEC Form 8-K/A filed by AVROBIO Inc.](https://www.quantisnow.com/insight/amendment-sec-form-8-ka-filed-by-avrobio-inc-5564465)
- 2024-06-14 20:35 UTC [Market Chatter] [AVROBIO Shareholders Approved Effecting Reverse Split At Ration In Range Of 1:3 And 1:30](https://www.quantisnow.com/insight/avrobio-shareholders-approved-effecting-reverse-split-at-ration-in-range-5559565)
- 2024-06-14 20:30 UTC [SEC Form 8-K] [SEC Form 8-K filed by AVROBIO Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-avrobio-inc-5559507)
- 2024-06-11 20:29 UTC [SEC Form 8-K] [SEC Form 8-K filed by AVROBIO Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-avrobio-inc-5551474)
- 2024-06-04 13:31 UTC [SEC Form 425] [SEC Form 425 filed by AVROBIO Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-avrobio-inc-5534908)
- 2024-06-04 13:30 UTC [SEC Form 8-K] [SEC Form 8-K filed by AVROBIO Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-avrobio-inc-5534905)
- 2024-06-03 21:24 UTC [SEC Form 425] [SEC Form 425 filed by AVROBIO Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-avrobio-inc-5533514)
- 2024-06-03 20:15 UTC [Leadership Update] [Tectonic Therapeutic Appoints Daniel Lochner as Chief Financial Officer](https://www.quantisnow.com/insight/tectonic-therapeutic-appoints-daniel-lochner-as-chief-financial-officer-5532802)
- 2024-05-28 20:05 UTC [SEC Form 425] [SEC Form 425 filed by AVROBIO Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-avrobio-inc-5519999)
- 2024-05-21 20:55 UTC [SEC Form 425] [SEC Form 425 filed by AVROBIO Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-avrobio-inc-5508008)
- 2024-05-21 14:01 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by AVROBIO Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-avrobio-inc-amendment-5506557)
- 2024-05-15 15:21 UTC [Insider Buy] [Leonard Braden Michael bought $971,493 worth of shares (766,635 units at $1.27) (SEC Form 4)](https://www.quantisnow.com/insight/leonard-braden-michael-bought-971493-worth-of-shares-766635-units-5492284)
- 2024-05-15 14:51 UTC [SEC Form 3] [New insider Leonard Braden Michael claimed ownership of 4,871,380 shares (SEC Form 3) (Amendment)](https://www.quantisnow.com/insight/new-insider-leonard-braden-michael-claimed-ownership-of-4871380-shares-5492201)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/AVRO
- Earnings history: https://www.quantisnow.com/earnings/AVRO
- Dividend history: https://www.quantisnow.com/dividends/AVRO
- Insider transactions: https://www.quantisnow.com/insiders/AVRO
- Options chain: https://www.quantisnow.com/options/AVRO
- SEC 8-K filings only: https://www.quantisnow.com/company/AVRO/8-k
- RSS and alerts for AVRO: https://www.quantisnow.com/docs/rss-feeds.md